Journal of Lipid Research

Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity.  61:1400-1409. 2020

Chylomicronemia from GPIHBP1 autoantibodies.  61:1365-1376. 2020

Macrophage polarization is linked to Ca²⁺-independent phospholipase A2β-derived lipids and cross-cell signaling in mice.  61:143-148. 2020

11β-Hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor γ.  60:1535-1546. 2019

Erratum: 12/15-Lipoxygenase-dependent ROS production is required for diet-induced endothelial barrier dysfunction (Journal of Lipid Research (2015) 56 (562–577) DOI: 10.1194/jlr.M055566).  60:909. 2019

Erratum: Comprehensive shotgun lipidomics of human meibomian gland secretions using MS/MS^all with successive switching between acquisition polarity modes (Journal of Lipid Research (2018) 59 (2223-2236) DOI: 10.1194/jlr.D088138).  60:1640. 2019

PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults.  60:1946-1952. 2019

Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: A hypothesis-generating prospective study of cardiovascular events in T1D.  60:1432-1439. 2019

An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort.  59:722-729. 2018

Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.  59:872-883. 2018

Bromofatty aldehyde derived from bromine exposure and myeloperoxidase and eosinophil peroxidase modify GSH and protein.  59:696-705. 2018

Comprehensive shotgun lipidomics of human meibomian gland secretions using MS/MS^all with successive switching between acquisition polarity modes.  59:2223-2236. 2018

Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.  59:2075-2083. 2018

Formation of chlorinated lipids post-chlorine gas exposure.  57:1529-1540. 2016

Carboxy-terminal mutations of bile acid CoA: N-acyltransferase alter activity and substrate specificity.  57:1133-1143. 2016

Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux.  57:1175-1193. 2016

Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge.  57:2200-2207. 2016

Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36.  57:2176-2184. 2016

Calcium-independent phospholipases A2 and their roles in biological processes and diseases.  56:1643-1668. 2015

Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.  56:871-887. 2015

12/15-Lipoxygenase-dependent ROS production is required for diet-induced endothelial barrier dysfunction.  56:562-577. 2015

KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression.  56:227-240. 2015

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: A review.  55:2007-2021. 2014

Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes.  55:860-869. 2014

Methylation at CPT1A locus is associated with lipoprotein subfraction profi les.  55:1324-1330. 2014

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid.  54:3403-3418. 2013

Enzymology of retinoic acid biosynthesis and degradation.  54:1744-1760. 2013

A novel approach to oral apoA-I mimetic therapy.  54:995-1010. 2013

CD36, but not G2A, modulates efferocytosis, infl ammation, and fibrosis following bleomycin-induced lung injury.  54:1114-1123. 2013

Validation of previous computer models and MD simulations of discoidal HDL by a recent crystal structure of apoA-I.  53:1851-1863. 2012

Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.  53:1576-1587. 2012

Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides.  53:849-858. 2012

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice.  53:437-445. 2012

Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos.  53:175-184. 2012

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.  52:1795-1809. 2011

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.  52:1200-1210. 2011

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice.  52:480-488. 2011

Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function.  52:435-450. 2011

Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.  51:3491-3499. 2010

Biological activities of 7-dehydrocholesterol-derived oxysterols: Implications for Smith-Lemli-Opitz syndrome.  51:3259-3269. 2010

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.  51:2695-2705. 2010

Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.  51:451-467. 2010

The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: The Sea Islands Genetic African American Registry (Project SuGAR).  51:586-597. 2010

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.  50:1538-1547. 2009

The role of dysfunctional HDL in atherosclerosis.  50. 2009

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.  49:2302-2311. 2008

Inactivation of human liver bile acid CoA:amino acid N-acyltransferase by the electrophilic lipid, 4-hydroxynonenal.  49:282-294. 2008

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.  49:192-205. 2008

Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-α gene transcription by the liver X receptor agonist T0-901317.  48:2647-2663. 2007

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits.  48:2344-2353. 2007

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.  48:1915-1923. 2007

The pathologies associated with functional titration of phosphatidylinositol transfer protein α activity in mice.  48:1857-1872. 2007

Quantification and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver.  48:1305-1315. 2007

D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.  47:2148-2160. 2006

Vitamin A combined with retinoic acid increases retinol uptake and lung retinyl ester formation in a synergistic manner in neonatal rats.  47:1844-1851. 2006

Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1.  47:107-114. 2006

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation.  46:1369-1379. 2005

Evidence of a distinct lipid fraction in historical parchments: A potential role in degradation?.  46:2726-2734. 2005

Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice.  46:1405-1415. 2005

Retina expresses microsomal triglyceride transfer protein: Implications for age-related maculopathy.  46:628-640. 2005

Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells.  45:1919-1928. 2004

Postprandial chylomicrons: Potent vehicles for transporting cholesterol from endogenous LDL+HDL and cell membranes to the liver via LCAT and CETP.  45:1242-1255. 2004

12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels.  44:2391-2399. 2003

Rat liver bile acid CoA:amino acid N-acyltransferase: Expression, characterization, and peroxisomal localization.  44:2242-2249. 2003

A quantitative analysis of apolipoprotein binding to SR-BI: Multiple binding sites for lipid-free and lipid-associated apolipoproteins.  44:1132-1142. 2003

Molecular cloning and expression of rat liver bile acid CoA ligase.  43:2062-2071. 2002

Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization.  43:1688-1700. 2002

Structure of apolipoprotein B-100 in low density lipoproteins.  42:1346-1367. 2001

Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.  42:1096-1104. 2001

Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.  42:959-966. 2001

A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.  42:545-552. 2001

Transgenic studies of fatty acid oxidation gene expression in nonobese diabetic mice.  41:2063-2070. 2000

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Step 1.  41:1481-1494. 2000

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3.  41:1495-1508. 2000

A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples.  41:1020-1026. 2000

Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: Structure-function relationships and studies in a compound heterozygous proband.  39:1870-1876. 1998

Quantification of HDL2 and HDL3 cholesterol by the vertical auto profile-II (VAP-II) methodology.  38:2353-2364. 1997

Effect of vesicle size on their interaction with class A amphipathic helical peptides.  38:2147-2154. 1997

Interaction of class A amphipathic helical peptides with phospholipid unilamellar vesicles.  38:2134-2146. 1997

Cloning, expression, and chromosomal localization of mouse liver bile acid CoA:amino acid N-acyltransferase.  38:1139-1148. 1997

Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper.  37:2361-2371. 1996

Probing structure and function of VLDL by synthetic amphipathic helical peptides.  37:1099-1112. 1996

Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology.  36:2291-2302. 1995

Imaging biliary lipid secretion in the rat: Ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane.  36:2147-2163. 1995

Role of apolipoprotein b-derived radical and α-tocopheroxyl radical in peroxidase-dependent oxidation of low density lipoprotein.  36:1037-1045. 1995

Quantification of cholesterol in all lipoprotein classes by the VAP-II method.  35:159-168. 1994

Role of bile salt hydrophobicity in hepatic microtubule-dependent bile salt secretion.  35:1738-1748. 1994

Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3.  34:1565-1572. 1993

Identification of bile acid coenzyme A synthetase in rat kidney.  34:95-99. 1993

Computer programs to identify and classify amphipathic α helical domains.  33:287-296. 1992

The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function.  33:141-166. 1992

Apolipoprotein A-I decreases neutrophil degranulation and superoxide production.  32:1911-1918. 1991

Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides.  31:407-416. 1990

Bile acid sulfotransferase I from rat liver sulfates bile acids and 3-hydroxy steroids: Purification, N-terminal amino acid sequence, and kinetic properties.  30:529-540. 1989

Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells.  30:1429-1436. 1989

Palmitic acid stimulates glucose incorporation in the adipocyte by a mechanism likely involving intracellular calcium.  30:1299-1305. 1989

Effect of oxidation on the properties of apolipoproteins A-1 and A-II.  29:309-318. 1988

Characterization of high density lipoprotein subspecies: Structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography.  28:913-929. 1987

Evidence for an ordered reaction mechanism for bile salt:3'phosphoadenosine-5'-phosphosulfate: Sulfotransferase from rhesus monkey liver that catalyzes the sulfation of the hepatotoxin glycolithocholate.  27:1111-1123. 1986

Nuclear magnetic resonance spectroscopy of bile acids. Development of two-dimensional NMR methods for the elucidation of proton resonance assignments for five common hydroxylated bile acids, and their parent bile acid, 5β-cholanoic acid.  26:1068-1078. 1985

Aggregation patterns of bile salts: Crystal structure of calcium cholate chloride heptahydrate.  25:791-798. 1984

High resolution nuclear magnetic resonance spectroscopy of bile salts: individual proton assignments for sodium cholate in aqueous solution at 400 MHz.  23:161-170. 1982

Enzymatic sulfation of glycochenodeoxycholic acid by tissue fractions from adult hamsters.  20:952-959. 1979